|
|
|
|
Epithelial Ovarian Cancer
The latest blood testing technology for epithelial ovarian cancer ... Feb 23, 2006
RxPG NEWS, Laboratory Corporation of America Holdings (LabCorp) for the commercialization of the university's blood testing technology for epithelial ovarian cancer (EOC ...
The early-warning signs of a silent killer Mar 5, 2006
The Herald, ...menstrual cycle. Around 90% of cases are epithelial ovarian cancer, forming in the cells that line the ovaries. Research published ...
LabCorp inks deal with Yale for ovarian cancer test Feb 24, 2006
Triad Business Journal, ...of America Holdings said it has signed an exclusive deal with Yale University to commercialize a test for epithelial ovarian cancer, the fourth-most common ...
LabCorp(R) Exclusively Licenses Yale Technology for New Early ... Feb 23, 2006
Yahoo! News (press release) ...entered into an exclusive license agreement with Yale University to commercialize the university's new blood testing technology for epithelial ovarian cancer. ...
Lose your bottle Mar 4, 2006
Sunday Herald, ...districts. Breastfeeding has major health benefits for mothers also, causing a reduction in breast cancer and epithelial ovarian cancer. ...
150 doctors participate in gynaecology seminar Jan 22, 2006
Ludhiana Newsline, The third session saw Dr Raman Arora from Mohan Dai Oswal Hospital, Ludhiana, speaking on the role of chemotherapy in epithelial ovarian cancer while Dr Satish ...
NCI clinical announcement: Intraperitoneal chemotherapy for ... Jan 5, 2006
Food Consumer, ...the time of diagnosis. Epithelial ovarian cancer appears to arise from the epithelial surface of the ovary. Spread of the disease ...
Early detection is key to overcoming ovarian cancer Jan 16, 2006
Centre Daily Times, Almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage and has spread to the upper ...
Abdominal Chemo Bests Traditional IV Treatment for Ovarian Cancer Jan 4, 2006
Forbes ...study has produced the largest survival advantage to date for patients with newly diagnosed, optimally debulked, stage III epithelial ovarian cancer," he said. ...
Drinking Tea Associated With Lower Risk Of Ovarian Cancer Jan 3, 2006
Science Daily (press release) ...per month. During an average follow-up of 15.1 years, 301 women were diagnosed as having invasive epithelial ovarian cancer. "We ...
BRCA1, BRCA2 Mutations Underestimated in Ovarian Cancer Jan 5, 2006
Cancerpage.com, Thus, it is recommended that genetic counseling be offered to all women with invasive, non-mucinous epithelial ovarian cancer.". ...
Treatment Advance in Ovarian Cancer Jan 5, 2006
Cancerpage.com, ...now recommends intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel in women with optimally debulked stage III epithelial ovarian cancer. ...
Tea Consumption Associated with a Decreased Incidence of Ovarian ... Dec 27, 2005
Cancer Consultants (press release), These researchers evaluated 301 women with invasive epithelial ovarian cancer among over 61,000 women aged 40 to 76 in a population-based cohort. ...
Drinking Tea Associated with Lower Risk of Ovarian Cancer Dec 16, 2005
DG News ...per month. During an average follow-up of 15.1 years, 301 women were diagnosed as having invasive epithelial ovarian cancer. "We ...
Tea drinkers have lower ovarian cancer risk Dec 14, 2005
FoodProductionDaily.com, ...more than once a month. Only 301 women were diagnosed as having invasive epithelial ovarian cancer. The researchers from the National ...
Tea Tippling Linked to Lower Ovarian Cancer Risk Dec 13, 2005
CNN 12 - Middle-age women who drink two or more cups of green or black tea every day may reduce their risk for invasive epithelial ovarian cancer by almost half ...
New research suggests link between tea consumption and decreased ... Dec 13, 2005
Drinks Business Review ...once per month. During 15.1 years of follow-up, 301 women were diagnosed as having epithelial ovarian cancer. The researchers found ...
Two Cups Of Tea A Day Lower Ovarian Cancer Risk By 46% Dec 13, 2005
Medical News Today, 68% drank tea once a month or more. The women were followed up until 2004. During this period 301 women developed invasive epithelial ovarian cancer. ...
Tea Consumption Reduces Ovarian Cancer Risk Dec 13, 2005
nutrilearn.com, STOCKHOLM, Sweden--Consuming black or green tea appears to reduce the risk of developing epithelial ovarian cancer in a dose-dependent manner, according to a ...
Sorafenib Shows Benefits in Combination with Gemcitabine in ... Nov 22, 2005
DG News ...phase 2 study is evaluating the efficacy and toxicity associated with the use of sorafenib plus gemcitabine in patients with recurrent epithelial ovarian cancer ...
Cuppa tip to cut cancer Dec 13, 2005
Australian, The researchers then tracked the women's progress for an average of 15 years, in which time 301 women were diagnosed with epithelial ovarian cancer.
Initial Surgery for Ovarian Cancer at Specialized Centers May ... Dec 1, 2005
Cancer Consultants (press release), Reference: Andersen E, Knudsen A, Svarrer T, et al. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. ...
Drinking apple juice may reduce oxidative damage associated with ... Dec 14, 2005
Natural Products Industry Insider, ...aged women. Women who frequently consume tea appear to be reducing their risk of developing epithelial ovarian cancer. LOWELL, Mass ...
Low CA-125 Suggests Better Prognosis for Stage I Ovarian Cancer Sep 6, 2005
According to a study published in the Journal of Clinical Oncology, women with stage I epithelial ovarian cancer have better survival if they have low pre ... Cancer Consultants (press release),
Study Suggests Protein May Be Early Warning For Ovarian Cancer Aug 16, 2005
...cancer.". Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... Science Daily (press release)
Protein to help early detection of ovarian cancer Aug 14, 2005
Mulder. Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... Newindpress,
Low CA-125 Suggests Better Prognosis for Stage I Ovarian Cancer -- Sep 6, 2005
According to a study published in the Journal of Clinical Oncology, women with stage I epithelial ovarian cancer have better survival if they have low pre ... / Cancer Consultants (press release),
Study Suggests Protein May Be Early Warning For Ovarian Cancer -- Aug 16, 2005
...cancer.". Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... / Science Daily (press release)
Researchers find ovarian cancer target -- Aug 15, 2005
...cancer. Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... / Pharmaceutical Business Review
Low CA-125 Suggests Better Prognosis for Stage I Ovarian Cancer Sep 6, 2005
According to a study published in the Journal of Clinical Oncology, women with stage I epithelial ovarian cancer have better survival if they have low pre ... Cancer Consultants (press release),
Study Suggests Protein May Be Early Warning For Ovarian Cancer Aug 16, 2005
...cancer.". Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... Science Daily (press release)
Protein to help early detection of ovarian cancer Aug 14, 2005
Mulder. Epithelial ovarian cancer is often diagnosed at an advanced stage and accounts for more than 16,000 deaths annually. Despite ... Newindpress,
Weekly Chemotherapy with Paclitaxel May Be Effective in Epithelial ... -- Jul 1, 2005
...weekly chemotherapy with the drug paclitaxel is well tolerated and may improve disease progression among women with advanced epithelial ovarian cancer who have ... / Cancer Consultants (press release),
La demenza rallenta il riflesso -- Jul 6, 2005
2005;294:47-55.). 30/06/2005 - Pillola breve fa scudo all’ovaio (Greer JB et al. Short-Term Oral Contraceptive Use and the Risk of Epithelial Ovarian Cancer. ... / Dica 33,
Short-Term Oral Contraceptive Use Decreases Ovarian Cancer Risk -- Jun 29, 2005
2005 (Reuters Health) - Short-term use of oral contraceptives (OC) offers significant protection against the risk of epithelial ovarian cancer, according to ... / Cancerpage.com,
COMUNICADO DE ELI LILLY AND COMPANY (2) -- Jul 5, 2005
Gemzar, in combination with carboplatin, is approved in several European markets for the treatment of recurrent epithelial ovarian cancer. ... / Europa Press,
Stopping an Elusive Killer -- Jun 27, 2005
...testing now. Epithelial ovarian cancer, the most common type, is usually not discovered until its advanced stages. Ovarian cancer ... / Washington Post,
Oral Contraceptive Use Reduces Risk of Ovarian Cancer -- Jun 30, 2005
Reference: Greer J, Modugno F, Allen G, Ness R. Short-Term Oral Contraceptive Use and the Risk of Epithelial Ovarian Cancer. American ... / Cancer Consultants (press release),
Contraception During Perimenopause -- Jun 22, 2005
50. Purdie DM, Bain CJ, Siskind V, et al. Ovulation and risk of epithelial ovarian cancer. ... Beyond ovulation: oral contraceptives and epithelial ovarian cancer. ... / RedNova.com,
Short-Term Oral Contraceptive Use and the Risk of Epithelial ... -- Jun 16, 2005
...association between short-term OC use and ovarian cancer in a population-based case-control study comparing 608 incident epithelial ovarian cancer cases with ... / Am. J.Epideminology (subscription),
Wine Drinking Lowers Risk of Gastric Cancer -- Jun 10, 2005
Early View (Articles published in advance of print) Published onlineDM, Bain CJ, et al. Alcohol, wine, and risk of epithelial ovarian cancer. ... / Cancer Consultants (press release),
Radiation Therapy May Be of Benefit in Women with Recurrent ... -- 17 Mar 2005
In this recent study, 35 patients diagnosed with recurrent epithelial ovarian cancer received radiation therapy between 1991 and 2001. ... / Cancer Consultants (press release),
Improved long-term survival in ovarian cancer -- Feb 22, 2005
...women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer. ... / Nature.com,
Involved Field Radiation Improves Outcomes for Women with ... -- Mar 11, 2005
States each year. Epithelial ovarian cancer is a malignancy that arises from the cells that cover the ovary. Current treatment consists ... / Cancer Consultants (press release),
Avastin® May Be Effective in Ovarian Cancer -- Mar 9, 2005
Reference: Monk B, Choi DC, Pubmire G, et al. Activity of bevacizumab (rhuMAB BEGF) in advanced refractory epithelial ovarian cancer. Gynecologic Oncology. ... / Cancer Consultants (press release),
New Test May Predict Poor Survival for Patients with Ovarian ... -- Feb 17, 2005
Oncology reports that a new test that examines insulin-like growth factor (IGF-2) may predict poor survival for patients with epithelial ovarian cancer. ... / Cancer Consultants (press release),
Doxil® Receives Full Approval for Recurrent Ovarian Cancer -- Mar 2, 2005
...and overall response rates. One trial in particular included 474 women with epithelial ovarian cancer. Patients were randomized ... / Cancer Consultants (press release),
Doxil® Receives Expanded Indication for Recurrent Ovarian Cancer -- Feb 17, 2005
...expanded indication for Doxil® was a phase III, randomized, multi-center, open-label trial that included 474 patients with recurrent epithelial ovarian cancer ... / Cancer Consultants (press release),
Relations of Gestational Length and Timing and Type of Incomplete ... -- Feb 17, 2005
Data collected from 739 epithelial ovarian cancer cases and 1,313 community controls in the Delaware Valley from 1994 to 1998 were used to evaluate the ... / Am. J.Epideminology (subscription),
New Drug Irofulven is Active against Metastatic Hormone-Refractory ... -- Feb 14, 2005
Phase 2 trials of Irofulven are being conducted in refractory or recurrent advanced epithelial ovarian cancer, hormone-refractory prostate cancer, recurrent ... / Cancer Consultants (press release),
Four Analytes that can Provide Early Detection of Epithelial ... May 10, 2005
Patricia Bray-Ward, Ph.D. of the Nevada Cancer Institute has identified four analytes that can provide early detection of epithelial ovarian cancer (EOC) in ... RxPG NEWS,
COX-1 eyed as target in ovarian cancer fight May 10, 2005
...to determine whether aspirin and other non-steroidal anti-inflammatory drugs, which block both COX enzymes, might improve treatment of epithelial ovarian cancer ... ScienceBlog.com
Test Can Predict Early Ovarian Cancer May 10, 2005
Epithelial ovarian cancer is the fourth-leading cause of cancer-related death in the United States. Three times more lethal than ... Sci-Tech Today
Ovarian cancer test offers promise May 10, 2005
...that the proteins leptin, prolactin, osteopontin, and insulin-like growth factor-II can make possible the early detection of epithelial ovarian cancer in women ... Las Vegas Review-Journal,
New test developed to spot ovarian cancer May 9, 2005
Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths in the United States and three times more lethal than breast cancer. Washington Times,
Blood Test Possible for Ovarian Cancer Screening May 9, 2005
Epithelial ovarian cancer is three times more deadly than breast cancer in the US Its diagnosis is difficult because few symptoms show up until its advanced ... Food Consumer,
Despite removal of tumor, much remains unresolved and confusing May 7, 2005
...several lymph nodes and how preliminary indications pointed toward a “low malignancy potential tumor,� also known as borderline epithelial ovarian cancer. ... Leesburg Daily Commercial,
New Study Results Demonstrate Clinical Effectiveness of Gemzar(R) ... May 16, 2005
Gemzar, in combination with carboplatin, is approved in several European markets for the treatment of recurrent epithelial ovarian cancer. ... Yahoo News (press release)
Dundee mums well short of target May 9, 2005
There is also evidence that women who breastfeed have lower risks of pre-menopausal breast cancer, epithelial ovarian cancer and hip fracture in later life. ... Evening Telegraph,
Radiation Therapy May Be of Benefit in Women with Recurrent ... 17 Mar 2005
In this recent study, 35 patients diagnosed with recurrent epithelial ovarian cancer received radiation therapy between 1991 and 2001. ... Cancer Consultants
Improved long-term survival in ovarian cancer Feb 22, 2005
...women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer. ... Nature.com
Involved Field Radiation Improves Outcomes for Women with ... Mar 11, 2005
States each year. Epithelial ovarian cancer is a malignancy that arises from the cells that cover the ovary. Current treatment consists ... Cancer Consultants
Avastin® May Be Effective in Ovarian Cancer Mar 9, 2005
Reference: Monk B, Choi DC, Pubmire G, et al. Activity of bevacizumab (rhuMAB BEGF) in advanced refractory epithelial ovarian cancer. Gynecologic Oncology. ... Cancer Consultants
New Test May Predict Poor Survival for Patients with Ovarian ... Feb 17, 2005
Oncology reports that a new test that examines insulin-like growth factor (IGF-2) may predict poor survival for patients with epithelial ovarian cancer. ... Cancer Consultants
Doxil® Receives Full Approval for Recurrent Ovarian Cancer Mar 2, 2005
...and overall response rates. One trial in particular included 474 women with epithelial ovarian cancer. Patients were randomized ... Cancer Consultants
Doxil® Receives Expanded Indication for Recurrent Ovarian Cancer Feb 17, 2005
...expanded indication for Doxil® was a phase III, randomized, multi-center, open-label trial that included 474 patients with recurrent epithelial ovarian cancer ... Cancer Consultants
Relations of Gestational Length and Timing and Type of Incomplete ... Feb 17, 2005
Data collected from 739 epithelial ovarian cancer cases and 1,313 community controls in the Delaware Valley from 1994 to 1998 were used to evaluate the ... Am. J.Epideminology (subscription)
New Drug Irofulven is Active against Metastatic Hormone-Refractory ... Feb 14, 2005
Phase 2 trials of Irofulven are being conducted in refractory or recurrent advanced epithelial ovarian cancer, hormone-refractory prostate cancer, recurrent ... Cancer Consultants
Ovarian Cancer Patients Begin Stem Cell Trial Sep 1, 2004
...marks Phase III of an ongoing study of the high-dose chemotherapy and stem cell replacement treatment in women with stage III invasive epithelial ovarian cancer ... CancerWise
Lilly's Alimta Approved For Advanced Lung Cancer Aug 19, 2004
Several European countries approved Gemzar, in combination with carboplatin, for the treatment of recurrent epithelial ovarian cancer. ... Inside INdiana Business
Elkoans may enter Medicare demonstration plan drawing Aug 20, 2004
These cancers include cutaneous T-cell lymphoma, nonsmall cell lung cancer, epithelial ovarian cancer, chronic myelogenous leukemia, GI stromal tumor, multiple ... Elko Daily Free Press
MD Anderson Cancer Center, Houston, Texas Jun 4, 2004
...intracellular steroid receptors (estrogen and progesterone receptors) are detected in 30%–71% of specimens from patients with epithelial ovarian cancer. ... Journal of Nuclear Medicine
Blood test hope for cancer sufferers May 17, 2004
...hormones. The most common form, accounting for 90% of cases, is epithelial ovarian cancer, which affects the surface layer of the ovary. ... The Herald
Sonographic Diagnosis of a Serous Tumor of Low Malignant ... May 21, 2004
Int J Gynecol Pathol 2000; 19:398–200.[Medline]. Ozols RF, Rubins SC, Dembo AJ, Robboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC (eds). ... Journal of Ultrasound in Medicine
Milk and lactose intakes and ovarian cancer risk in the Swedish ... -- Nov 5, 2004
Objective: We examined the association between intakes of dairy products and lactose and the risk of total epithelial ovarian cancer and its subtypes. ... / Am J Clin Nutr (subscription),
Nodal Induces Apoptosis and Inhibits Proliferation in Human ... -- Nov 4, 2004
Canada M3J 1P3. E-mail: cpeng@yorku.ca. Human epithelial ovarian cancer is the most lethal female cancer. Hormones and growth factors ... / Journal of Clinical Endocrinology and Metabolism,
FDA Approves Alimta (pemetrexed) for the Second Line Treatment of ... -- Oct 22, 2004
Several European countries approved Gemzar, in combination with carboplatin, for the treatment of recurrent epithelial ovarian cancer. ... / Onlypunjab.com,
Q&A: What to Know About Ovarian Cancer -- Sep 1, 2004
...outside of the ovary. The risk of epithelial ovarian cancer increases with age, especially after the age of 50. Germ Cell: Germ ... / CancerWise
Ovarian Cancer Patients Begin Stem Cell Trial -- Sep 1, 2004
...marks Phase III of an ongoing study of the high-dose chemotherapy and stem cell replacement treatment in women with stage III invasive epithelial ovarian cancer ... / CancerWise
Lilly's Alimta Approved For Advanced Lung Cancer -- Aug 19, 2004
Several European countries approved Gemzar, in combination with carboplatin, for the treatment of recurrent epithelial ovarian cancer. ... / Inside INdiana Business (press release),
Elkoans may enter Medicare demonstration plan drawing -- Aug 20, 2004
These cancers include cutaneous T-cell lymphoma, nonsmall cell lung cancer, epithelial ovarian cancer, chronic myelogenous leukemia, GI stromal tumor, multiple ... / Elko Daily Free Press,
|
|
|
